title: Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
authors.affiliation: RAND Health, RAND Corporation, Santa Monica, Los Angeles, CA 90407, USA. rminhas@rand.org
authors.forename: R
authors.initials: R
authors.lastname: Minhas
authors.forename: S E
authors.initials: SE
authors.lastname: Humphries
authors.forename: N
authors.initials: N
authors.lastname: Qureshi
authors.forename: H A W
authors.initials: HA
authors.lastname: Neil
mesh_terms: D000367:Age Factors; D000368:Aged; D002784:Cholesterol / Q000097:blood / Q000235:genetics; D003362:Cost-Benefit Analysis; D005192:Family Health; D005260:Female; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000627:therapeutic use; D006938:Hyperlipoproteinemia Type II / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D008297:Male; D008875:Middle Aged; D017422:Sequence Analysis, DNA
chemical_list: D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases